MAOIS AND REBOXETINE

No data seem to be available about the concurrent use of reboxetine with MAOIs. However, the manufacturers predict that a hypertensive reaction is possible.
Concurrent use should be avoided. With other drugs that interact in the manner predicted it is usually advised that concurrent use should also be avoided for 2 weeks after the MAOI has been stopped.